tradingkey.logo

Intelligent Bio Solutions Inc

INBS
6.230USD
-0.090-1.42%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
5.67MMarktkapitalisierung
VerlustKGV TTM

Intelligent Bio Solutions Inc

6.230
-0.090-1.42%

mehr Informationen über Intelligent Bio Solutions Inc Unternehmen

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc Informationen

BörsenkürzelINBS
Name des UnternehmensIntelligent Bio Solutions Inc
IPO-datumDec 23, 2020
CEOSimeonidis (Harry)
Anzahl der mitarbeiter16
WertpapierartOrdinary Share
GeschäftsjahresendeDec 23
Addresse135 W 41St St,
StadtNEW YORK
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl10036
Telefon16467905756
Websitehttps://ibs.inc/
BörsenkürzelINBS
IPO-datumDec 23, 2020
CEOSimeonidis (Harry)

Führungskräfte von Intelligent Bio Solutions Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
4.04K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
6.00
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
4.04K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
6.00
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United Kingdom
1.07M
96.14%
Rest of world
36.22K
3.26%
Americas
4.97K
0.45%
Australia
1.69K
0.15%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Fri, Jan 30
Aktualisiert: Fri, Jan 30
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Alyeska Investment Group, L.P.
5.54%
Adar1 Capital Management LLC
3.51%
Geode Capital Management, L.L.C.
0.48%
Sakiris (Spiro Kevin)
0.44%
Warberg Asset Management LLC
0.37%
Andere
89.66%
Aktionäre
Aktionäre
Anteil
Alyeska Investment Group, L.P.
5.54%
Adar1 Capital Management LLC
3.51%
Geode Capital Management, L.L.C.
0.48%
Sakiris (Spiro Kevin)
0.44%
Warberg Asset Management LLC
0.37%
Andere
89.66%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
9.41%
Individual Investor
0.78%
Investment Advisor
0.56%
Investment Advisor/Hedge Fund
0.48%
Research Firm
0.18%
Andere
88.59%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
30
129.36K
10.64%
-1.19K
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Alyeska Investment Group, L.P.
67.35K
5.54%
+5.96K
+9.71%
Sep 30, 2025
Adar1 Capital Management LLC
42.64K
3.51%
+42.64K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
5.89K
0.48%
+742.00
+14.42%
Sep 30, 2025
Sakiris (Spiro Kevin)
5.39K
0.44%
--
--
Sep 11, 2025
Warberg Asset Management LLC
4.47K
0.37%
+4.47K
--
Sep 30, 2025
Simeonidis (Harry)
4.04K
0.33%
--
--
Sep 11, 2025
LPL Financial LLC
2.50K
0.21%
+2.50K
--
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.28K
0.11%
--
--
Sep 30, 2025
Citi Investment Research (US)
935.00
0.08%
+935.00
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Datum
Ex-Dividendentag
Art
Verhältnis
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
KeyAI